XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Statements of Changes in Shareholders' Deficit (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Subscription Receivable [Member]
Total
Balance at Apr. 26, 2023
Balance, shares at Apr. 26, 2023        
Net Income (loss) (3,618) (3,618)
Issuance of Founder Shares to Sponsor for subscription receivable [1] $ 144 24,856 (25,000)
Issuance of Founder Shares to Sponsor for subscription receivable, shares [1] 1,437,500        
Balance at Jun. 30, 2023 $ 144 24,856 (3,618) (25,000) (3,618)
Balance, shares at Jun. 30, 2023 1,437,500        
Balance at Dec. 31, 2023 $ 213 (134,337) (134,124)
Balance, shares at Dec. 31, 2023 2,126,000        
Remeasurement of ordinary shares subject to possible redemption (909,132) (909,132)
Net Income (loss) 755,500   755,500
Balance at Mar. 31, 2024 $ 213 (287,969) (287,756)
Balance, shares at Mar. 31, 2024 2,126,000        
Balance at Dec. 31, 2023 $ 213 (134,337) (134,124)
Balance, shares at Dec. 31, 2023 2,126,000        
Net Income (loss)         1,364,592
Balance at Jun. 30, 2024 $ 213 (597,083) (596,870)
Balance, shares at Jun. 30, 2024 2,126,000        
Balance at Mar. 31, 2024 $ 213 (287,969) (287,756)
Balance, shares at Mar. 31, 2024 2,126,000        
Remeasurement of ordinary shares subject to possible redemption (918,206)   (918,206)
Net Income (loss) 609,092 609,092
Balance at Jun. 30, 2024 $ 213 $ (597,083) $ (596,870)
Balance, shares at Jun. 30, 2024 2,126,000        
[1] As of June 30, 2023 excludes up to an aggregate of 187,500 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part (see Note 5). As a result of the underwriters’ full exercise of their over-allotment option on December 6, 2023, no founder shares are currently subject to forfeiture for June 30, 2024.